Current best evidence on prescribed drugs

Drugdocs Logo

Current best evidence on prescribed drugs

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Tymlos

Chemical Nameabaloparatide
Dosage FormInjection (subcutaneous; 3120 mcg/1.56 mL)
Drug ClassAnalogs
SystemMusculoskeletal
CompanyRadius Health
Approval Year2017

Indication

  • For the treatment of postmenopausal women with osteoporosis at high risk for fracture
Last updated on 4/25/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Tymlos (abaloparatide) Prescribing Information.2018Radius Health, Inc., Waltham, MA
Document TitleYearSource
Anabolic therapies for osteoporosis in postmenopausal women: effectiveness and value. 2017ICER
Document TitleYearSource
Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: a systematic review and network meta-analysis of randomized controlled trials.2019Maturitas
Document TitleYearSource
American Association Of Clinical Endocrinologists/American College Of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2020 update.2020Endocrine
Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society Clinical Practice Guideline.2019The Journal of Clinical Endocrinology